FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Oliver Galm

Research Profile

Physiology

Chemicals & Drugs

Disorders

Anatomy

Genes & Molecular Sequences

Concepts & Ideas

Treatment Outcome

Procedures

Co-author Network

Publications

TOP 3
Rainer Claus; Hartmut Döhner; Konstanze Döhner; Oliver Galm; Björn Hackanson; Jan Hiller; Michael Lübbert; Uwe Platzbecker; Anna R Poetsch; Miriam Sonnet; Stefan Wilop; Manuela Zucknick; Nadja Blagitko-Dorfs; Tim H Brümmendorf; John C Byrd; Christoph Plass
Quantitative analyses of DAPK1 methylation in AML and MDS.
Rainer Claus; Edgar Dahl; Oliver Galm; Thomas Hielscher; Edgar Jost; Miriam Sonnet; Stefan Wilop; Christoph Plass
A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR.
Michael Lübbert; Uwe Platzbecker; Volker Rethwisch; Björn H Rüter; Mathias Schmid; Claudia Schmoor; Pierre W Wijermans; Wolfram Brugger; Rainer Claus; Barbara Deschler; Konstanze Döhner; Oliver Galm; Arnold Ganser; Ulrich Germing; Björn Hackanson; Anne Hagemeijer; Gerhard Heil; Andrea Kuendgen; Hartmut Döhner
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Oliver Galm (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Rainer Claus; Hartmut Döhner; Konstanze Döhner; Oliver Galm; Björn Hackanson; Jan Hiller; Michael Lübbert; Uwe Platzbecker; Anna R Poetsch; Miriam Sonnet; Stefan Wilop; Manuela Zucknick; Nadja Blagitko-Dorfs; Tim H Brümmendorf; John C Byrd; Christoph Plass
Quantitative analyses of DAPK1 methylation in AML and MDS.
International journal of cancer. Journal international du cancer 2012;131(2):E138-42.
2012: Rainer Claus; Edgar Dahl; Oliver Galm; Thomas Hielscher; Edgar Jost; Miriam Sonnet; Stefan Wilop; Christoph Plass
A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR.
Epigenetics : official journal of the DNA Methylation Society 2012;7(7):772-80.
2012: Michael Lübbert; Uwe Platzbecker; Volker Rethwisch; Björn H Rüter; Mathias Schmid; Claudia Schmoor; Pierre W Wijermans; Wolfram Brugger; Rainer Claus; Barbara Deschler; Konstanze Döhner; Oliver Galm; Arnold Ganser; Ulrich Germing; Björn Hackanson; Anne Hagemeijer; Gerhard Heil; Andrea Kuendgen; Hartmut Döhner
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy.
Haematologica 2012;97(3):393-401.
2012: Karla Bennemann; Tim H Brümmendorf; Oliver Galm; Claudia Schubert; Stefan Wilop; Edgar Jost
Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation.
Clinical epigenetics 2012;4(1):12.
2012: Daniela C Kroy; Sara Sackett; Leif E Sander; Stephanie Erschfeld; Oliver Galm; Nikolaus Gassler; Lisa Hebing; Christian Trautwein; Konrad L Streetz
Differential role of gp130-dependent STAT and Ras signalling for haematopoiesis following bone-marrow transplantation.
PloS one 2012;7(6):e39728.
2011: Stefan Wilop; James G Herman; Edgar Jost; Tim H Brümmendorf; Manel Esteller; Agustín F Fernandez; Oliver Galm
Array-based DNA methylation profiling in acute myeloid leukaemia.
British journal of haematology 2011;155(1):65-72.
2011: Christoph Oing; Stefan Wilop; Tim H Brümmendorf; Edgar Dahl; Edgar Jost; Oliver Galm
Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemia.
Clinical epigenetics 2011;2(2):419-23.
2011: Stefan Wilop; Tim H Brümmendorf; James G Herman; Edgar Jost; Marjolein H F M Lentjes; Manon van Engeland; Thomas B van Gemmeren; Oliver Galm
Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma.
Epigenetics : official journal of the DNA Methylation Society 2011;6(8):1047-52.
2011: Thomas Walenda; Gudrun Bokermann; Edgar Jost; Oliver Galm; Anne Schellenberg; Carmen M Koch; Daniela M Piroth; Wolf Drescher; Tim H Brümmendorf; Wolfgang Wagner
Serum after autologous transplantation stimulates proliferation and expansion of human hematopoietic progenitor cells.
PloS one 2011;6(3):e18012.
2010: Iris Middeldorf; Oliver Galm; Rainhardt Osieka; Edgar Jost; James G Herman; Stefan Wilop
Sequence of administration and methylation of SOCS3 may govern response to gemtuzumab ozogamicin in combination with conventional chemotherapy in patients with refractory or relapsed acute myelogenous leukemia (AML).
American journal of hematology 2010;85(7):477-81.
2010: Maximilian Hatting; Oliver Galm; Martin Meyer; Christian Trautwein; Jens J W Tischendorf
[Anemia and severe thrombocytopenia in celiac disease].
Medizinische Klinik (Munich, Germany : 1983) 2010;105(4):249-52.
2010: Stefan Wilop; Oliver Galm; Laura Thompson; Rainhardt Osieka; Tim H Brummendorf; Edgar Jost
Friday leukemia: myth or reality?
Blood 2010;115(4):912.
2009: Ying Ye; A MICHAEL MCDEVITT; Mingzhou Guo; Wei Zhang; Oliver Galm; Steven D Gore; Judith E Karp; Jaroslaw P Maciejewski; Jeanne Kowalski; Hua-Ling Tsai; Lukasz Gondek; Hsing-Chen Tsai; Xiaofei Wang; Craig M Hooker; B Douglas Smith; Hetty Carraway; James G Herman
Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.
Cancer research 2009;69(21):8482-90.
2009: Edgar Jost; D Gezer; Stefan Wilop; H Suzuki; James G Herman; Rainhardt Osieka; Oliver Galm
Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma.
Cancer letters 2009;281(1):24-31.
2009: Stefan Wilop; Reyad Dada; Oliver Galm; Peter Jousten; Rainhardt Osieka; Edgar Jost
Cisplatin as single-agent chemotherapy in patients with liver dysfunction due to metastases.
Onkologie 2009;32(7):400-4.
2009: Mehmet K Tur; Inga Neef; Edgar Jost; Oliver Galm; Gernot Jäger; Michael Stöcker; Markus Ribbert; Rainhardt Osieka; Uwe Klinge; Stefan Barth
Targeted restoration of down-regulated DAPK2 tumor suppressor activity induces apoptosis in Hodgkin lymphoma cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(5):431-41.
2009: Barbara Seeliger; Stefan Wilop; Rainhardt Osieka; Oliver Galm; Edgar Jost
CpG island methylation patterns in chronic lymphocytic leukemia.
Leukemia & lymphoma 2009;50(3):419-26.
2009: Edgar Jost; Nicole do O; Stefan Wilop; James G Herman; Rainhardt Osieka; Oliver Galm
Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
Leukemia research 2009;33(3):443-9.
2009: Reyad Dada; Stefan Wilop; Edgar Jost; Oliver Galm; Nikolaus Gassler; Rainhardt Osieka
Successful treatment of hepatic encephalopathy in a patient with acute lymphoblastic leukemia.
Acta haematologica 2009;122(4):216-20.
2009: F Wiesmann; Jürgen Veeck; Oliver Galm; Arndt Hartmann; Manel Esteller; Ruth Knüchel; Edgar Dahl
Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer.
Breast cancer research : BCR 2009;11(3):R34.
2009: Jason P W Carey; Ananthi J Asirvatham; Oliver Galm; Tandeih A Ghogomu; Jaideep Chaudhary
Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.
BMC cancer 2009;9():173.
2008: Stefan Wilop; Oliver Galm; Reyad Dada; Rainhardt Osieka; Edgar Jost
Rituximab-associated changes in platelet count in patients with non-Hodgkin lymphoma.
Leukemia & lymphoma 2008;49(11):2116-24.
2008: Edgar Jost; J Schmid; Stefan Wilop; C Schubert; H Suzuki; James G Herman; R Osieka; Oliver Galm
Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
British journal of haematology 2008;142(5):745-53.
2008: Erik Noetzel; Jürgen Veeck; Dieter Niederacher; Oliver Galm; Felicitas Horn; Arndt Hartmann; Ruth Knüchel; Edgar Dahl
Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer.
BMC cancer 2008;8():154.
2007: Martina Crysandt; Britta Neumann; Marco Das; Vera Engelbertz; Michael Bendel; Oliver Galm; Rainhardt Osieka; Edgar Jost
Intraperitoneal application of rituximab in refractory mantle cell lymphoma with massive ascites resulting in local and systemic response.
European journal of haematology 2007;79(6):546-9.
2007: Edgar Jost; P Kiefer; Joseph Neulen; Oliver Galm; Rainhardt Osieka
Post-partum acquired haemophilia after IVF without recurrence during a second pregnancy obtained by IVF.
Human reproduction (Oxford, England) 2007;22(8):2348-9.
2007: Edgar Jost; Oliver Galm
EHA scientific workshop report: the role of epigenetics in hematological malignancies.
Epigenetics : official journal of the DNA Methylation Society 2007;2(2):71-9.
2007: Edgar Jost; N do O; Edgar Dahl; C E Maintz; P Jousten; L Habets; Stefan Wilop; James G Herman; Rainhardt Osieka; Oliver Galm
Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders.
Leukemia 2007;21(3):505-10.
2006: Steven D Gore; Stephen B Baylin; Elizabeth Sugar; Hetty Carraway; Carole B Miller; Michael A Carducci; Michael R Grever; Oliver Galm; Tianna Dauses; Judith E Karp; MICHELLE RUDEK-RENAUT; Ming Zhao; B Douglas Smith; Jasper Manning; Anchalee Jiemjit; George J Dover; Abbie Mays; James Zwiebel; Anthony J Murgo; Li-Jun Weng; James G Herman
Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms.
Cancer research 2006;66(12):6361-9.
2006: Jürgen Veeck; Dieter Niederacher; H An; Eva Klopocki; F Wiesmann; Beate Betz; Oliver Galm; O Camara; Matthias Dürst; Glen Kristiansen; C Huszka; Ruth Knüchel; Edgar Dahl
Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis.
Oncogene 2006;25(24):3479-88.
2006: Oliver Galm; James G Herman; Stephen B Baylin
The fundamental role of epigenetics in hematopoietic malignancies.
Blood reviews 2006;20(1):1-13.
2005: Edgar Jost; J Lorenzen; P Haage; G Bos; D Beelen; Oliver Galm; Gerald Gehbauer; Rainhardt Osieka
Heart and muscle involvement by extra-medullary myeloid leukemia: a case report and review of the literature.
Leukemia & lymphoma 2005;46(12):1819-24.
2005: Oliver Galm; Stefan Wilop; Christian Lüders; Edgar Jost; Gerald Gehbauer; James G Herman; Rainhardt Osieka
Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
Annals of hematology 2005;84 Suppl 1():39-46.
2005: Oliver Galm; Hiromu Suzuki; Yoshimitsu Akiyama; Manel Esteller; Malcolm V Brock; Rainhardt Osieka; Stephen B Baylin; James G Herman
Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignancies.
Oncogene 2005;24(30):4799-805.
2005: Oliver Galm; James G Herman
Methylation-specific polymerase chain reaction.
Methods in molecular medicine 2005;113():279-91.
2004: Oliver Galm; Stefan Wilop; J Reichelt; Edgar Jost; Gerald Gehbauer; James G Herman; Rainhardt Osieka
DNA methylation changes in multiple myeloma.
Leukemia 2004;18(10):1687-92.
2004: Oliver Galm; Manel Esteller
Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies.
International journal of hematology 2004;80(2):120-7.
2003: Ursula Fabry; Elisabeth Kohne; Oliver Galm; Rainhardt Osieka
[HbH disease--a rare differential diagnosis in a patient with anemia and abdominal pain].
Medizinische Klinik (Munich, Germany : 1983) 2003;98(6):335-8.
2003: Oliver Galm; Hirohide Yoshikawa; Manel Esteller; Rainhardt Osieka; James G Herman
SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma.
Blood 2003;101(7):2784-8.
2002: Oliver Galm; Ursula Fabry; Thomas Efferth; Rainhardt Osieka
Synergism between rViscumin and cisplatin is not dependent on ERCC-1 expression.
Cancer letters 2002;187(1-2):143-51.
2002: Manel Esteller; Mingzhou Guo; Victor Moreno; Miquel Angel Peinado; Gabriel Capella; Oliver Galm; Stephen B Baylin; James G Herman
Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer.
Cancer research 2002;62(20):5902-5.
2002: Manel Esteller; Mario F Fraga; Maria Fe Paz; Elias Campo; Dolors Colomer; Francisco J Novo; María J Calasanz; Oliver Galm; Mingzhou Guo; Javier Benitez; James G Herman
Cancer epigenetics and methylation.
Science (New York, N.Y.) 2002;297(5588):1807-8; discussion 1807-8.
2002: Oliver Galm; Michael R Rountree; Kurtis E Bachman; Kam-Wing Jair; Stephen B Baylin; James G Herman
Enzymatic regional methylation assay: a novel method to quantify regional CpG methylation density.
Genome research 2002;12(1):153-7.
2001: O Maywald; Oliver Galm; Ursula Fabry; Elisabeth Kohne; Rainhardt Osieka
[An unusual etiology of erythrocytosis in a 23-year-old primiparous woman in the 22nd week of pregnancy].
Medizinische Klinik (Munich, Germany : 1983) 2001;96(1):45-9.
2001: Oliver Galm; Ursula Fabry; G Adam; Rainhardt Osieka
Pneumatosis intestinalis following cytotoxic or immunosuppressive treatment.
Digestion 2001;64(2):128-32.
2000: Oliver Galm; Ursula Fabry; Rainhardt Osieka
Pseudotumor cerebri after treatment of relapsed acute promyelocytic leukemia with arsenic trioxide.
Leukemia 2000;14(2):343-4.